Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
For new submissions from 1st January 2019, authors will need to pay an article publishing charge (APC) of £1690.00/$2400.00/€2040.00 for each article submitted and accepted for publication in the journal.
Aims and Scope
Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.
Annual Journal Metrics
60 days to first decision for reviewed manuscripts only
35 days to first decision for all manuscripts
117 days from submission to acceptance
19 days from acceptance to publication
106 Altmetric Mentions